Literature DB >> 19556685

Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans.

A Knopf1, K Parodi, T Bortfeld, H A Shih, H Paganetti.   

Abstract

The clinical use of offline positron emission tomography/computed tomography (PET/CT) scans for proton range verification is currently under investigation at the Massachusetts General Hospital (MGH). Validation is achieved by comparing measured activity distributions, acquired in patients after receiving one fraction of proton irradiation, with corresponding Monte Carlo (MC) simulated distributions. Deviations between measured and simulated activity distributions can either reflect errors during the treatment chain from planning to delivery or they can be caused by various inherent challenges of the offline PET/CT verification method. We performed a systematic analysis to assess the impact of the following aspects on the feasibility and accuracy of the offline PET/CT method: (1) biological washout processes, (2) patient motion, (3) Hounsfield unit (HU) based tissue classification for the simulation of the activity distributions and (4) tumor site specific aspects. It was found that the spatial reproducibility of the measured activity distributions is within 1 mm. However, the feasibility of range verification is restricted to a limited amount of positions and tumor sites. Washout effects introduce discrepancies between the measured and simulated ranges of about 4 mm at positions where the proton beam stops in soft tissue. Motion causes spatial deviations of up to 3 cm between measured and simulated activity distributions in abdominopelvic tumor cases. In these later cases, the MC simulated activity distributions were found to be limited to about 35% accuracy in absolute values and about 2 mm in spatial accuracy depending on the correlativity of HU into the physical and biological parameters of the irradiated tissue. Besides, for further specific tumor locations, the beam arrangement, the limited accuracy of rigid co-registration and organ movements can prevent the success of PET/CT range verification. All the addressed factors explain why the proton beam range can only be verified within an accuracy of 1-2 mm in low-perfused bony structures of head and neck patients for which an accurate co-registration of predominant bony anatomy is possible, as shown previously. However, most of the limitations of the current approach are conquerable. By implementing technological and methodological improvements like the use of in-room PET scanners, PET measurements could soon be used to provide proton range verification in clinical routine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556685     DOI: 10.1088/0031-9155/54/14/008

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  20 in total

1.  Optimizing a three-stage Compton camera for measuring prompt gamma rays emitted during proton radiotherapy.

Authors:  S W Peterson; D Robertson; J Polf
Journal:  Phys Med Biol       Date:  2010-11-03       Impact factor: 3.609

2.  Monitoring proton therapy with PET.

Authors:  H Paganetti; G El Fakhri
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

3.  Monitoring proton radiation therapy with in-room PET imaging.

Authors:  Xuping Zhu; Samuel España; Juliane Daartz; Norbert Liebsch; Jinsong Ouyang; Harald Paganetti; Thomas R Bortfeld; Georges El Fakhri
Journal:  Phys Med Biol       Date:  2011-06-15       Impact factor: 3.609

4.  Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy.

Authors:  Nora Hünemohr; Harald Paganetti; Steffen Greilich; Oliver Jäkel; Joao Seco
Journal:  Med Phys       Date:  2014-06       Impact factor: 4.071

5.  Mapping (15)O production rate for proton therapy verification.

Authors:  Kira Grogg; Nathaniel M Alpert; Xuping Zhu; Chul Hee Min; Mauro Testa; Brian Winey; Marc D Normandin; Helen A Shih; Harald Paganetti; Thomas Bortfeld; Georges El Fakhri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-25       Impact factor: 7.038

6.  Proton radiography and fluoroscopy of lung tumors: a Monte Carlo study using patient-specific 4DCT phantoms.

Authors:  Bin Han; X George Xu; George T Y Chen
Journal:  Med Phys       Date:  2011-04       Impact factor: 4.071

7.  The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy.

Authors:  S España; X Zhu; J Daartz; G El Fakhri; T Bortfeld; H Paganetti
Journal:  Phys Med Biol       Date:  2011-04-05       Impact factor: 3.609

8.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

9.  Feasibility of Using Distal Endpoints for In-room PET Range Verification of Proton Therapy.

Authors:  Kira Grogg; Xuping Zhu; Chul Hee Min; Brian Winey; Thomas Bortfeld; Harald Paganetti; Helen A Shih; Georges El Fakhri
Journal:  IEEE Trans Nucl Sci       Date:  2013-10       Impact factor: 1.679

10.  Determination of elemental tissue composition following proton treatment using positron emission tomography.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Chul Hee Min; Xuping Zhu; Georges El Fakhri; Harald Paganetti; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-05-16       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.